MYBPC3 myosin binding protein C3
Also known as: cMyBP-C, FHC, MYBP-C, myosin-binding protein C, cardiac.
Approximate pronunciation (generated from the name, not a recording):
- MYBPC3 em-why-bee-pee-see-three
- myosin binding protein C3 myosin binding protein see-three
What this gene does
The MYBPC3 gene provides instructions for making cardiac myosin binding protein C (cardiac MyBP-C), which is found in heart (cardiac) muscle cells. In these cells, cardiac MyBP-C is associated with a structure called the sarcomere, which is the basic unit of muscle contraction. Sarcomeres are made up of thick and thin filaments. The overlapping thick and thin filaments attach to each other and release, which allows the filaments to move relative to one another so that muscles can contract. Regular contractions of cardiac muscle pump blood to the rest of the body.
In cardiac muscle sarcomeres, cardiac MyBP-C attaches to thick filaments and keeps them from being broken down prematurely. Cardiac MyBP-C has molecules called phosphate groups attached to it; when the phosphate groups are removed, cardiac MyBP-C is broken down, followed by the breakdown of proteins of the thick filament. Cardiac MyBP-C also regulates how fast muscles contract, although the mechanism is not fully understood.
Source: MedlinePlus Genetics (reviewed 2017-06; source updated 2025-11-19).
Familial hypertrophic cardiomyopathy
Approximate pronunciation (generated from the name, not a recording):
- Familial hypertrophic cardiomyopathy familial hypertrophic cardiomyopathy
Also known as: Brock's disease, Familial asymmetric septal hypertrophy, HCM, Hereditary ventricular hypertrophy, Heritable hypertrophic cardiomyopathy, Idiopathic hypertrophic subaortic stenosis, Subaortic hypertrophic stenosis.
What is Familial hypertrophic cardiomyopathy?
Hypertrophic cardiomyopathy is a heart condition characterized by thickening (hypertrophy) of the heart (cardiac) muscle. When multiple members of a family have the condition, it is known as familial hypertrophic cardiomyopathy. Hypertrophic cardiomyopathy also occurs in people with no family history; these cases are considered nonfamilial hypertrophic cardiomyopathy.
In familial hypertrophic cardiomyopathy, cardiac thickening usually occurs in the interventricular septum, which is the muscular wall that separates the lower left chamber of the heart (the left ventricle) from the lower right chamber (the right ventricle). In some people, thickening of the interventricular septum impedes the flow of oxygen-rich blood from the heart, which may lead to an abnormal heart sound during a heartbeat (heart murmur) and other signs and symptoms of the condition. Other affected individuals do not have physical obstruction of blood flow, but the pumping of blood is less efficient, which can also lead to symptoms of the condition. Familial hypertrophic cardiomyopathy often begins in adolescence or young adulthood, although it can develop at any time throughout life.
The symptoms of familial hypertrophic cardiomyopathy are variable, even within the same family. Many affected individuals have no symptoms. Other people with familial hypertrophic cardiomyopathy may experience chest pain; shortness of breath, especially with physical exertion; a sensation of fluttering or pounding in the chest (palpitations); lightheadedness; dizziness; and fainting.
While most people with familial hypertrophic cardiomyopathy are symptom-free or have only mild symptoms, this condition can have serious consequences. It can cause abnormal heart rhythms (arrhythmias) that may be life threatening. People with familial hypertrophic cardiomyopathy have an increased risk of sudden death, even if they have no other symptoms of the condition. A small number of affected individuals develop potentially fatal heart failure, which may require heart transplantation.
Nonfamilial hypertrophic cardiomyopathy tends to be milder. This form typically begins later in life than familial hypertrophic cardiomyopathy, and affected individuals have a lower risk of serious cardiac events and sudden death than people with the familial form.
Source: MedlinePlus Genetics (reviewed 2023-01; source updated 2024-09-17).
How it is inherited
Nonsyndromic hypertrophic cardiomyopathy has different inheritance patterns depending on the specific gene involved. When nonsyndromic hypertrophic cardiomyopathy occurs in multiple family members, it may be called familial hypertrophic cardiomyopathy.
Nonsyndromic hypertrophic cardiomyopathy is typically inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder. However, some people who have the altered gene never develop features of the condition. This is known as incomplete penetrance.
Although many individuals with nonsyndromic hypertrophic cardiomyopathy have a parent with the condition, some people have the condition as a result of a new (de novo) variant in a gene that occurs during the formation of reproductive cells (eggs or sperm) in an individual's parent or during early embryonic development.
Some cases of nonsyndromic hypertrophic cardiomyopathy are inherited in an autosomal recessive pattern, which means both copies of the gene in each cell must have a pathogenic variant to cause the disorder. The parents of an individual with an autosomal recessive condition each carry one copy of the altered gene, but they typically do not show signs and symptoms of the condition.
In rare cases, affected individuals have a pathogenic variant in two or more genes that are associated with the condition. This can lead to more severe signs and symptoms.
When hypertrophic cardiomyopathy is part of a syndrome, it follows the inheritance pattern of that syndrome.
Source: MedlinePlus Genetics (reviewed 2023-01; source updated 2024-09-17).
How common it is
MedlinePlus Genetics Frequency
Hypertrophic cardiomyopathy affects approximately 1 in 500 people worldwide. Nonsyndromic hypertrophic cardiomyopathy likely accounts for more than half of all cases.
Source: MedlinePlus Genetics (reviewed 2023-01; source updated 2024-09-17).
Research studies
76 studies recruiting people with Familial hypertrophic cardiomyopathy. Showing the first 5 of 76.
- A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy (NCT07023614)
- A Study to Assess the Real-World Effectiveness of Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopathy in China (NCT07361289)
- Stress Echo 2030: the Novel ABCDE-(FGLPR) Protocol to Define the Future of Imaging (NCT05081115)
- Effectiveness and Treatment Patterns of Mavacamten in Patients With Obstructive Hypertrophic Cardiomyopathy in Japan (MANAGE-HCM) (NCT07541833)
- BHB-1893 Versus Metoprolol for Symptomatic Obstructive Hypertrophic Cardiomyopathy (NCT07755904)
See all recruiting studies on ClinicalTrials.gov.
Source: ClinicalTrials.gov (retrieved 2026-10-04).
Family and care
What a diagnosis can mean for a family, and what to ask. This guidance is general, not specific to one gene.
What is a genetic consultation?
A genetic consultation is a health service that provides information and support to people who have, or may be at risk for, genetic conditions. During a consultation, a genetics professional meets with an individual or family to discuss genetic risks or to diagnose, confirm, or rule out a genetic condition.
Genetics professionals include medical geneticists (doctors who specialize in genetics) and genetic counselors (certified healthcare workers with experience in medical genetics and counseling). Other healthcare professionals such as nurses, psychologists, and social workers trained in genetics can also provide genetic consultations.
Consultations usually take place in a doctor’s office, hospital, genetics center, or other type of medical center. These meetings are most often in-person visits with individuals or families, but they are occasionally conducted in a group. Additionally, genetic consultations may be carried out using telemedicine (also known as telehealth), in which the meeting is done from a distance using computers, cameras, videoconferencing tools, or the telephone.
Source: MedlinePlus Genetics.
Why might someone have a genetic consultation?
Individuals or families who are concerned about an inherited condition may benefit from a genetic consultation. The reasons that a person might be referred to a genetic counselor, medical geneticist, or other genetics professional include:
A personal or family history of a genetic condition, birth defect, chromosomal disorder, or hereditary cancer.
Two or more pregnancy losses (miscarriages), a stillbirth, or a baby who died.
A child with a known inherited disorder, a birth defect, intellectual disability, or developmental delay.
A woman who is pregnant or plans to become pregnant at or after age 35. (Some chromosomal disorders occur more frequently in children born to older women.)
Abnormal test results that suggest a genetic or chromosomal condition.
An increased risk of developing or passing on a particular genetic disorder on the basis of a person’s ethnic background.
People related by blood (for example, cousins) who plan to have children together. (A child whose parents are related may be at an increased risk of inheriting certain genetic disorders.)
A person received results from direct-to-consumer genetic testing and they want to discuss the implications of the results.
A genetic consultation is also an important part of the decision-making process for genetic testing. A visit with a genetics professional may be helpful even if testing is not available for a specific condition, however.
Source: MedlinePlus Genetics.
What happens during a genetic consultation?
A genetic consultation provides information, offers support, and addresses a patient’s specific questions and concerns. To help determine whether a condition has a genetic component, a genetics professional asks about a person’s medical history and takes a detailed family health history (a record of health information about a person's immediate and extended family). The genetics professional may also perform a physical examination and recommend appropriate medical tests.
If a person is diagnosed with a genetic condition, the genetics professional provides information about the diagnosis, how the condition is inherited, the chance of passing the condition to future generations, and the options for testing and treatment.
During a consultation, a genetics professional will:
Interpret and communicate complex medical information.
Help each person make informed, independent decisions about their health care and reproductive options.
Respect each person’s individual beliefs, traditions, and feelings.
A genetics professional will NOT:
Tell a person which decision to make.
Coerce a couple about whether or not to have children.
Recommend that a woman continue or end a pregnancy.
Tell someone whether to undergo testing for a genetic disorder.
Source: MedlinePlus Genetics.
What is genetic counseling?
The goal of genetic counseling is to help you learn more about the causes of genetic conditions and how they affect you.
Genetic counselors can: Review your family and medical histories; Explain how genetic conditions are passed down through families; Figure out if you or your family members are at risk for disease; Find and give you information about genetic conditions; Offer guidance to help you make informed choices or life plans; Provide information about testing options and help you decide what is best for you and your family; Help you find referrals to medical specialists, advocacy and support networks, and other resources.
Source: National Society of Genetic Counselors and Genetic Alliance (CC BY; published 2008).
Where to go next
- Familial hypertrophic cardiomyopathy: Hypertrophic Cardiomyopathy Association — The patient advocacy organization for Familial hypertrophic cardiomyopathy.
- Find a Genetic Counselor (NSGC) — Find a genetic counselor near you.
- Search ClinicalTrials.gov for Familial hypertrophic cardiomyopathy — Look for studies that are recruiting people with Familial hypertrophic cardiomyopathy.
Words you may meet
Some technical words appear in the sections above and in the details below. Here is what they mean, in words from a public genetics glossary.
- Gene
- The gene is considered the basic unit of inheritance. Genes are passed from parents to offspring and contain the information needed to specify physical and biological traits. Most genes code for specific proteins, or segments of proteins, which have differing functions within the body. Humans have approximately 20,000 protein-coding genes. NHGRI Talking Glossary of Genomic and Genetic Terms
- Chromosome
- Chromosomes are threadlike structures made of protein and a single molecule of DNA that serve to carry the genomic information from cell to cell. In plants and animals (including humans), chromosomes reside in the nucleus of cells. Humans have 22 pairs of numbered chromosomes (autosomes) and one pair of sex chromosomes (XX or XY), for a total of 46. Each pair contains two chromosomes, one coming from each parent, which means that children inherit half of their chromosomes from their mother and half from their father. Chromosomes can be seen through a microscope when the nucleus dissolves during cell division. NHGRI Talking Glossary of Genomic and Genetic Terms
- Autosomal Recessive Disorder
- Autosomal recessive is a pattern of inheritance characteristic of some genetic disorders. “Autosomal” means that the gene in question is located on one of the numbered, or non-sex, chromosomes. “Recessive” means that two copies of the mutated gene (one from each parent) are required to cause the disorder. In a family where both parents are carriers and do not have the disease, roughly a quarter of their children will inherit two disease-causing alleles and have the disease. By contrast, an autosomal dominant disorder requires only a single copy of the mutated gene from one parent to cause the disorder. Sickle cell anemia is an example of an autosomal recessive genetic disorder. NHGRI Talking Glossary of Genomic and Genetic Terms
- Autosomal Dominant Disorder
- Autosomal dominant is a pattern of inheritance characteristic of some genetic disorders. “Autosomal” means that the gene in question is located on one of the numbered, or non-sex, chromosomes. “Dominant” means that a single copy of the mutated gene (from one parent) is enough to cause the disorder. A child of a person affected by an autosomal dominant condition has a 50% chance of being affected by that condition via inheritance of a dominant allele. By contrast, an autosomal recessive disorder requires two copies of the mutated gene (one from each parent) to cause the disorder. Huntington’s disease is an example of an autosomal dominant genetic disorder. NHGRI Talking Glossary of Genomic and Genetic Terms
- Mitochondrial DNA
- Mitochondrial DNA is the circular chromosome found inside the cellular organelles called mitochondria. Located in the cytoplasm, mitochondria are the site of the cell’s energy production and other metabolic functions. Offspring inherit mitochondria — and as a result mitochondrial DNA — from their mother. NHGRI Talking Glossary of Genomic and Genetic Terms
- Genetic Imprinting
- Genomic imprinting is the process by which only one copy of a gene in an individual (either from their mother or their father) is expressed, while the other copy is suppressed. Unlike genomic mutations that can affect the ability of inherited genes to be expressed, genomic imprinting does not affect the DNA sequence itself. Instead, gene expression is silenced by the epigenetic addition of chemical tags to the DNA during egg or sperm formation. Epigenetic tags on imprinted genes usually stay in place for the life of the individual. NHGRI Talking Glossary of Genomic and Genetic Terms
- Protein
- Proteins are large, complex molecules that play many important roles in the body. They are critical to most of the work done by cells and are required for the structure, function and regulation of the body’s tissues and organs. A protein is made up of one or more long, folded chains of amino acids (each called a polypeptide), whose sequences are determined by the DNA sequence of the protein-encoding gene. NHGRI Talking Glossary of Genomic and Genetic Terms
- Mutation
- A mutation is a change in the DNA sequence of an organism. Mutations can result from errors in DNA replication during cell division, exposure to mutagens or a viral infection. Germline mutations (that occur in eggs and sperm) can be passed on to offspring, while somatic mutations (that occur in body cells) are not passed on. NHGRI Talking Glossary of Genomic and Genetic Terms
- Pathogenic Variant
- A pathogenic variant is a genomic variant that may increase a person’s risk of developing a condition, disorder or disease. In many cases, carrying a pathogenic variant does not guarantee that a person will develop the specific condition but increases the risk for it. Pathogenic variants can be inherited from a parent or can occur spontaneously due to factors such as environmental exposure and aging. NHGRI Talking Glossary of Genomic and Genetic Terms
- Genetic Testing
- Genetic testing is the use of a laboratory test to examine an individual’s DNA for variations, typically performed in the context of medical care, ancestry studies or forensics. In a medical setting, the results of a genetic test can be used to confirm or rule out a suspected genetic disease. Results may also be used to determine the likelihood of parents passing on a genetic mutation to their offspring. Genetic testing may be performed prenatally or after birth. Genetic testing is also used to study the genomes of tumors in cancer cases. NHGRI Talking Glossary of Genomic and Genetic Terms
- Carrier
- A carrier, as related to genetics, is an individual who “carries” and can pass on to its offspring a genomic variant (allele) associated with a disease (or trait) that is inherited in an autosomal recessive or sex-linked manner, and who does not show symptoms of that disease (or features of that trait). The carrier has inherited the variant allele from one parent and a normal allele from the other parent. Any offspring of carriers is at risk of inheriting a variant allele from their parents, which would result in that child having the disease (or trait). NHGRI Talking Glossary of Genomic and Genetic Terms
- Allele
- An allele is one of two or more versions of DNA sequence (a single base or a segment of bases) at a given genomic location. An individual inherits two alleles, one from each parent, for any given genomic location where such variation exists. If the two alleles are the same, the individual is homozygous for that allele. If the alleles are different, the individual is heterozygous. NHGRI Talking Glossary of Genomic and Genetic Terms
- Mendelian Inheritance
- Mendelian inheritance refers to certain patterns of how traits are passed from parents to offspring. These general patterns were established by the Austrian monk Gregor Mendel, who performed thousands of experiments with pea plants in the 19th century. Mendel’s discoveries of how traits (such as color and shape) are passed down from one generation to the next introduced the concept of dominant and recessive modes of inheritance. NHGRI Talking Glossary of Genomic and Genetic Terms
Details you may see on a test report
These names and numbers are the technical ones doctors and labs use. You do not need to memorize them.
Location
This is where the gene sits on its chromosome, so you can match it to coordinates on a test report.
11p11.2 · GRCh38 chr11:47,331,406–47,352,702
Open in Ensembl (primary) or UCSC Genome Browser (secondary).
Source: HGNC (HGNC:7551).
Recommended transcript
This is the reference transcript labs use when they report a change in this gene.
- MANE Select
NM_000256.3(RefSeq) /ENST00000545968.6(Ensembl)
Source: NCBI MANE.
Protein domains
These are the working parts of the protein, with the amino-acid positions each one covers.
- Immunoglobulin subtype 2 — amino acids 22–88, 376–443, 466–535, 662–758, 986–1050, 1193–1260
- Immunoglobulin domain subtype — amino acids 16–95, 161–257, 370–450, 460–541, 551–637, 656–769, 980–1063, 1187–1271
- Fibronectin type III — amino acids 772–870, 870–967, 1066–1163
- Immunoglobulin-like domain — amino acids 153–255, 360–438, 452–525, 645–765, 971–1059, 1181–1269
- Immunoglobulin I-set — amino acids 11–85, 157–256, 365–439, 456–527, 548–616, 710–768, 981–1062, 1181–1270
- MyBP-C, tri-helix bundle domain — amino acids 320–353
Protein structure
This lets you look at the protein's 3D shape if you want to.
View the predicted structure in AlphaFold, or search the PDB for solved structures.
Source: UniProt (Q14896).
Reported gene variants
ClinVar collects gene variants people have reported; it is a place to search, not a list on this page.
This page does not list individual variants. Search ClinVar for MYBPC3 instead.
Source: ClinVar.
What this page is not
This page is for education only. It is not medical advice, and it is not a diagnosis or a treatment plan. Talk with a doctor or a genetic counselor about your family's situation.